The purpose of this study is to determine the safety and effectiveness of ethylene diamine
tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
Phase:
Phase 3
Details
Lead Sponsor:
Mt. Sinai Medical Center, Miami
Collaborators:
National Center for Complementary and Integrative Health (NCCIH) National Heart, Lung, and Blood Institute (NHLBI)